The Battle of the Injectables in T2D Management CME

The goal of this activity is to help clinicians understand the major differences between glucagon-like peptide-1 (GLP-1) therapy and insulin, as well as where and when to use them in the treatment of type 2 diabetes (T2D). Patient education points regarding these 2 injectable therapies for T2D ar...